Patents Assigned to Caprion Proteomics Inc.
  • Patent number: 10191063
    Abstract: The present invention provides biomarkers, methods and kits for diagnosing a Brucellosis, Q-Fever, and/or Lyme Disease, methods and kits for monitoring the effectiveness of treatment for Brucellosis, Q-Fever, or Lyme Disease, as well as methods for identifying a compound that can treat Brucellosis, Q-Fever, and/or Lyme Disease reduce or inhibit the development of complications associated with the disease in a subject, and methods to treat a Brucellosis, Q-Fever, and/or Lyme Disease.
    Type: Grant
    Filed: September 4, 2015
    Date of Patent: January 29, 2019
    Assignee: Caprion Proteomics Inc.
    Inventors: Eustache Paramithiotis, Pascal Croteau
  • Patent number: 9857378
    Abstract: The present invention provides biomarkers, methods and kits for diagnosing active tuberculosis in a subject, methods and kits for monitoring the effectiveness of treatment for active TB, as well as methods for identifying a compound that can treat TB reduce or inhibit the development of complications associated with the disease in a subject, and methods to treat active TB.
    Type: Grant
    Filed: August 26, 2015
    Date of Patent: January 2, 2018
    Assignees: Caprion Proteomics Inc., Albert Einstein College of Medicine, Inc.
    Inventors: Eustache Paramithiotis, Pascal Croteau, Jacqueline Michele Achkar